MK-677 vs CJC-1295: What Is the Difference in Research? MK-677 and CJC-1295 are often grouped together because both are studied in relation to growth hormone and insulin-like growth factor 1 signaling. That shared downstream interest can hide an important distinction: they are different compound types and engage different upstream pathways. MK-677, also known as ibutamoren,…
GLP-based compounds are among the most talked-about areas of metabolic research today. From GLP-1 receptor agonists such as semaglutide to the dual-receptor activity of tirzepatide and the investigational triple-receptor activity of retatrutide, research in this field continues to evolve rapidly. Most conversations focus on one outcome: weight loss. But there is much more for researchers…
What Is LL-37? Antimicrobial and Immune Signaling Research Explained LL-37 is often introduced as an antimicrobial peptide, but that description captures only one part of its biology. Researchers also study LL-37 as a signaling molecule involved in innate immunity, immune-cell recruitment, epithelial barriers, inflammation, and tissue responses. Because LL-37 can behave differently depending on concentration,…
Search interest in Dihexa is growing as more people encounter discussions about cognitive research, neuroplasticity, and the HGF/c-Met signaling pathway. The most important fact, however, is often left out: the published Dihexa evidence remains preclinical. Dihexa is an experimental angiotensin IV-derived compound investigated in laboratory and animal models involving synapse formation, learning, memory, and neuronal…
Tirzepatide, Survodutide, Mazdutide and Retatrutide are all studied in metabolic research, but they do not activate the same combination of receptors. Tirzepatide targets GLP-1 and GIP receptors. Survodutide and Mazdutide target GLP-1 and glucagon receptors. Retatrutide brings all three pathways—GLP-1, GIP and glucagon—into one research model. Mile High Peptides LLC is a U.S.-based supplier of…
What Is Mazdutide (IBI362)? GLP-1 & Glucagon Receptor Research Explained Mazdutide, also known as IBI362 and LY3305677, is a peptide studied for activity involving two important metabolic receptor systems: the GLP-1 receptor and the glucagon receptor. Because Mazdutide interacts with both receptor systems, it is classified as a dual GLP-1/glucagon receptor agonist. In simple terms,…
You must be 21 or older to enter this site.
